Pelthos Therapeutics Inc. PTHS Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$51.59M-601% | -$43.32M-445% | -$23.58M-134% | -$9.04M+7.7% | -$7.36M+18.0% | ||
| —— | —— | —— | —— | $0— | ||
| $6.88M+245% | $5.46M+204% | $4.19M+103% | $1.95M+3.3% | $1.99M+13.6% | ||
| -$35.08M-692% | -$22.59M-290% | -$17.01M-210% | -$1.93M+65.3% | -$4.43M-58.3% | ||
| —— | —— | —— | —— | $0— | ||
| —— | $2.76M— | $2.07M— | $1.38M— | $690.25K— | ||
| —— | —— | —— | —— | $0— | ||
| $443K-32.1% | $693K+29.3% | $827K+96.0% | $893K+136% | $652K— | ||
| $72.61M— | $45.34M— | —— | —— | —— | ||
| $32.1M— | $17.51M— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pelthos Therapeutics Inc. generate?
- Pelthos Therapeutics Inc. (PTHS) generated -$35.1M in operating cash flow over the trailing twelve months.
- What is Pelthos Therapeutics Inc.'s free cash flow?
- After $194.0K of capital expenditures, Pelthos Therapeutics Inc.'s free cash flow was -$16.8M over the trailing twelve months.
- Where does Pelthos Therapeutics Inc.'s cash flow data come from?
- Every line is extracted from Pelthos Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
